Migdal Insurance & Financial Holdings’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Migdal Insurance & Financial Holdings's EW Position: Q2 2026 in Review
Migdal Insurance & Financial Holdings sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 761 shares — an estimated $60.9K sold.
Migdal Insurance & Financial Holdings first reported a position in EW in Q1 2018 and held it in 15 quarters. The position peaked at $1.7M in Q2 2020. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Migdal Insurance & Financial Holdings reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
- Migdal Insurance & Financial Holdings sold 761 Edwards Lifesciences shares in Q2 2026, an estimated $60.9K.
- Migdal Insurance & Financial Holdings first reported a position in Edwards Lifesciences in Q1 2018 and held it in 15 quarters.
- Migdal Insurance & Financial Holdings's Edwards Lifesciences position peaked at $1.7M in Q2 2020.
- 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2026, filed 10 Aug 2026.